FibroGen, Inc. FGEN
9.07 USD 0.00 (+0.00%)
Jan 12, 2026, 9:30 AM EST
9.02 Day range 9.21
52-week range unavailable
- YTD
- +3.30%
- 1 year
- -41.90%
FGEN revenue history
Revenue is income from the company’s ordinary business activities.
29,621,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 29,621,000 | -17,182,000 | -36.71% |
| FY 2023 | 2023-12-31 | 46,803,000 | -93,931,000 | -66.74% |
| FY 2022 | 2022-12-31 | 140,734,000 | -94,575,000 | -40.19% |
| FY 2021 | 2021-12-31 | 235,309,000 | 58,990,000 | 33.46% |
| FY 2020 | 2020-12-31 | 176,319,000 | -80,258,000 | -31.28% |
| FY 2019 | 2019-12-31 | 256,577,000 | 43,619,000 | 20.48% |
| FY 2018 | 2018-12-31 | 212,958,000 | 81,962,000 | 62.57% |
| FY 2017 | 2017-12-31 | 130,996,000 | -52,193,000 | -28.49% |
| FY 2016 | 2016-12-31 | 183,189,000 | 2,361,000 | 1.31% |
| FY 2015 | 2015-12-31 | 180,828,000 | 43,227,000 | 31.41% |
| FY 2014 | 2014-12-31 | 137,601,000 | 35,431,000 | 34.68% |
| FY 2013 | 2013-12-31 | 102,170,000 | 36,237,000 | 54.96% |
| FY 2012 | 2012-12-31 | 65,933,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-11-14T15:36:11.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.